The Vaccines Market is a critical, high-growth segment of the global pharmaceutical and biotechnology industry, focused on developing and manufacturing biological preparations to provide active acquired immunity to a particular infectious disease. It is segmented into prophylactic (preventive) and therapeutic vaccines, serving both pediatric and adult demographics. (2026-2033)
Global Vaccines Market is set for robust expansion. The total revenue is projected to grow from approximately USD 84.18 billion in 2025 to an estimated USD 137.24 billion by 2033. This translates to a strong Compound Annual Growth Rate (CAGR) of around 6.3% throughout the forecast period, emphasizing the sustained global investment in preventive medicine and cutting-edge biotechnology.
Showing the single result
-
Oncolytic Virus Therapy Market Analysis by Product Type (HSV-based, Adenovirus-based, Vaccinia Virus...
Price range: $3,499.00 through $5,499.00Select options This product has multiple variants. The options may be chosen on the product pageReport ID : | No. of Pages : | Base Year for Estimate :The oncolytic virus therapy market is projected to grow from an estimated value of $0.19 billion in 2024 to $0.23 billion in 2025, and further to approximately $19.97 billion by 2034, exhibiting a CAGR of around 19.23% from 2025 to 2034.